This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Applied Genetic Technologies Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Wichtige Informationen
6.5%
Wachstumsrate der Gewinne
29.5%
EPS-Wachstumsrate
| Biotechs Gewinnwachstum | 28.2% |
| Wachstumsrate der Einnahmen | 68.0% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | n/a |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
AGTC receives positive feedback from FDA for manufacturing facility
Jul 26Applied Genetic Technologies proposes stock offering to fund clinical trials
Jul 12Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022
Jan 12An Assessment Of Applied Genetic Technologies Corporation
Dec 14Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk
Jul 15Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?
May 21
Applied Genetic trades lower after announcing the departure of chief scientific officer
Apr 26What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?
Feb 05
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?
Jan 06What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 11Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic
Nov 11Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 6/30/2025 | 12 | -100 | -127 | -99 | 2 |
| 6/30/2024 | N/A | -90 | -110 | -93 | 3 |
| 6/30/2023 | 0 | -78 | -96 | -87 | 5 |
| 9/30/2022 | 0 | -70 | -68 | -66 | N/A |
| 6/30/2022 | 0 | -69 | -68 | -66 | N/A |
| 3/31/2022 | 1 | -63 | -63 | -61 | N/A |
| 12/31/2021 | 1 | -63 | -60 | -58 | N/A |
| 9/30/2021 | 1 | -60 | -56 | -54 | N/A |
| 6/30/2021 | 1 | -58 | -53 | -51 | N/A |
| 3/31/2021 | N/A | -60 | -53 | -52 | N/A |
| 12/31/2020 | N/A | -57 | -50 | -49 | N/A |
| 9/30/2020 | 2 | -50 | -45 | -44 | N/A |
| 6/30/2020 | 2 | -46 | -43 | -42 | N/A |
| 3/31/2020 | 3 | -42 | -37 | -35 | N/A |
| 12/31/2019 | 24 | -19 | -34 | -34 | N/A |
| 9/30/2019 | 28 | -15 | -35 | -35 | N/A |
| 6/30/2019 | 42 | -2 | -24 | -23 | N/A |
| 3/31/2019 | 47 | 2 | -23 | -23 | N/A |
| 12/31/2018 | 29 | -18 | -24 | -23 | N/A |
| 9/30/2018 | 28 | -19 | -24 | -23 | N/A |
| 6/30/2018 | 24 | -21 | -33 | -33 | N/A |
| 3/31/2018 | 27 | -18 | -37 | -36 | N/A |
| 12/31/2017 | 32 | -11 | -37 | -37 | N/A |
| 9/30/2017 | 38 | -4 | -35 | -34 | N/A |
| 6/30/2017 | 39 | 0 | -32 | -31 | N/A |
| 3/31/2017 | 43 | 6 | -29 | -28 | N/A |
| 12/31/2016 | 47 | 10 | -31 | -28 | N/A |
| 9/30/2016 | 48 | 11 | -32 | -30 | N/A |
| 6/30/2016 | 47 | -1 | N/A | 71 | N/A |
| 3/31/2016 | 36 | -12 | N/A | 72 | N/A |
| 12/31/2015 | 24 | -20 | N/A | 75 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: AGTC is forecast to remain unprofitable over the next 3 years.
Ertrag vs. Markt: AGTC is forecast to remain unprofitable over the next 3 years.
Hohe Wachstumserträge: AGTC is forecast to remain unprofitable over the next 3 years.
Einnahmen vs. Markt: AGTC's revenue (68% per year) is forecast to grow faster than the US market (7% per year).
Hohe Wachstumseinnahmen: AGTC's revenue (68% per year) is forecast to grow faster than 20% per year.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Insufficient data to determine if AGTC's Return on Equity is forecast to be high in 3 years time